Mitesco, Inc. (MITI)
OTCMKTS: MITI · Delayed Price · USD
0.290
0.00 (0.00%)
Jul 1, 2024, 11:37 AM EDT - Market closed
Mitesco Revenue
Mitesco had revenue of $16.04K in the twelve months ending March 31, 2024, down -97.19% year-over-year.
Revenue (ttm)
$16.04K
Revenue Growth
-97.19%
P/S Ratio
107.30
Revenue / Employee
$5,347
Employees
3
Market Cap
1.72M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 690.53K | 574.54K | 495.32% |
Dec 31, 2021 | 115.99K | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 3.50K | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 227.66K | 51.22K | 29.03% |
Dec 31, 2013 | 176.44K | 17.08K | 10.72% |
Dec 31, 2012 | 159.36K | - | - |
Jun 30, 2011 | 0 | - | - |
Jun 30, 2010 | 0 | - | - |
Jun 30, 2009 | 0 | - | - |
Jun 30, 2008 | 0 | - | - |
Jun 30, 2007 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
MITI News
- 2 months ago - Mitesco Expands Advisory Board With Senior Technology, Infrastructure Execs - GlobeNewsWire
- 2 months ago - Mitesco Announces Investor Call, Begins New Data Center and Infrastructure Initiative - GlobeNewsWire
- 3 months ago - Mitesco Announces Advisory Board Appointments - GlobeNewsWire
- 4 months ago - Mitesco Continues Key Initiatives, Updates - GlobeNewsWire
- 4 months ago - Mitesco Provides Shareholder Update - GlobeNewsWire
- 1 year ago - Mitesco Appoints Mr. Allen Plunk to its Board of Directors - GlobeNewsWire
- 1 year ago - Mitesco Moves Emphasis to Acquisitions & Strategic Initiatives - GlobeNewsWire
- 1 year ago - Mitesco, Inc. Continues on Uplist Path, Evaluates Potential Joint Venture and Alternative Funding Opportunities for The Good Clinic Business - GlobeNewsWire